Dai Ichi Life Insurance Company Ltd increased its position in shares of Everest Re Group, Ltd. (NYSE:RE) by 7.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,570 shares of the insurance provider’s stock after buying an additional 1,607 shares during the period. Dai Ichi Life Insurance Company Ltd owned about 0.06% of Everest Re Group worth $6,255,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Renaissance Technologies LLC increased its stake in shares of Everest Re Group by 3.1% during the first quarter. Renaissance Technologies LLC now owns 174,900 shares of the insurance provider’s stock valued at $40,893,000 after buying an additional 5,200 shares during the period. OMERS ADMINISTRATION Corp purchased a new position in shares of Everest Re Group during the second quarter valued at $1,451,000. Wellington Management Group LLP increased its stake in shares of Everest Re Group by 21.5% during the first quarter. Wellington Management Group LLP now owns 86,593 shares of the insurance provider’s stock valued at $20,246,000 after buying an additional 15,328 shares during the period. Menta Capital LLC increased its stake in shares of Everest Re Group by 350.0% during the first quarter. Menta Capital LLC now owns 4,860 shares of the insurance provider’s stock valued at $1,136,000 after buying an additional 3,780 shares during the period. Finally, UBS Group AG increased its stake in shares of Everest Re Group by 15.3% during the first quarter. UBS Group AG now owns 55,548 shares of the insurance provider’s stock valued at $12,988,000 after buying an additional 7,368 shares during the period. Hedge funds and other institutional investors own 92.39% of the company’s stock.

Shares of Everest Re Group, Ltd. (NYSE RE) traded up 4.6451% during midday trading on Monday, reaching $232.8144. The company had a trading volume of 553,911 shares. The company has a market capitalization of $9.56 billion, a P/E ratio of 7.9881 and a beta of 0.64. The company’s 50 day moving average price is $257.71 and its 200-day moving average price is $248.94. Everest Re Group, Ltd. has a 52 week low of $183.04 and a 52 week high of $277.17.

Everest Re Group (NYSE:RE) last issued its quarterly earnings results on Monday, July 24th. The insurance provider reported $5.51 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $5.24 by $0.27. Everest Re Group had a return on equity of 13.60% and a net margin of 19.65%. The company had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.46 billion. During the same quarter in the prior year, the business earned $3.17 EPS. On average, equities research analysts predict that Everest Re Group, Ltd. will post $21.25 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 20th. Shareholders of record on Wednesday, September 6th will be issued a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, September 1st. This represents a $5.00 annualized dividend and a yield of 2.25%. Everest Re Group’s dividend payout ratio (DPR) is 17.15%.

Several equities analysts have recently commented on the company. Buckingham Research assumed coverage on Everest Re Group in a research note on Monday. They set a “neutral” rating and a $255.00 price target on the stock. ValuEngine lowered Everest Re Group from a “strong-buy” rating to a “buy” rating in a research note on Thursday. Barclays PLC raised their price target on Everest Re Group from $299.00 to $305.00 and gave the company an “overweight” rating in a research note on Friday, August 11th. Zacks Investment Research lowered Everest Re Group from a “buy” rating to a “hold” rating in a research note on Wednesday, August 2nd. Finally, UBS AG restated a “neutral” rating and set a $256.00 price target (up previously from $251.00) on shares of Everest Re Group in a research note on Tuesday, August 1st. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $250.78.

TRADEMARK VIOLATION WARNING: “Dai Ichi Life Insurance Company Ltd Increases Stake in Everest Re Group, Ltd. (RE)” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/09/11/dai-ichi-life-insurance-company-ltd-increases-stake-in-everest-re-group-ltd-re.html.

Everest Re Group Company Profile

Everest Re Group, Ltd., through its subsidiaries, is engaged in the underwriting of reinsurance and insurance in the United States, Bermuda and international markets. The Company operates in segments: U.S. Reinsurance, International, Bermuda and Insurance segment. The Company underwrites reinsurance both through brokers and directly with ceding companies.

Want to see what other hedge funds are holding RE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everest Re Group, Ltd. (NYSE:RE).

Institutional Ownership by Quarter for Everest Re Group (NYSE:RE)

Receive News & Stock Ratings for Everest Re Group Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everest Re Group Ltd. and related stocks with our FREE daily email newsletter.